You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Aldosterone Blockade

Showing 1 - 25 of 1,865
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Salt Taste Threshold in Patients Being Investigated for Primary

Unknown status
  • Hyperaldosteronism; Primary
  • +3 more
  • adrenalectomy
  • Aldosterone Antagonist
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Sep 15, 2020

Endstage Renal Disease Trial in Worldwide (Spironolactone 25Mg Tablet, Placebo Oral Tablet)

Recruiting
  • Endstage Renal Disease
  • Spironolactone 25Mg Tablet
  • Placebo Oral Tablet
  • Garran, Australian Capital Territory, Australia
  • +85 more
Sep 19, 2022

Primary Aldosteronism, Endocrine Hypertension Trial (Cinnarizine, NIFEdipine ER)

Not yet recruiting
  • Primary Aldosteronism
  • Endocrine Hypertension
  • (no location specified)
Jan 12, 2023

Heart Failure Trial in Italy (Canrenone)

Completed
  • Heart Failure
  • Ancona, Italy
  • +44 more
Feb 2, 2021

Primary Aldosteronism, Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral) Trial in Boston (Amlodipine)

Recruiting
  • Primary Aldosteronism
  • Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
  • Boston, Massachusetts
    Anand Vaidya
Nov 26, 2021

Primary Aldosteronism in Blacks

Recruiting
  • Adrenal Gland Neoplasm
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 11, 2022

    Heart Failure Trial in Edmonton (Spironolactone, Placebo)

    Completed
    • Heart Failure
    • Edmonton, Alberta, Canada
      University of Alberta Hospital
    Nov 5, 2018

    Hypertension, Left Ventricular Hypertrophy Trial (Eplerenone, Chlorthalidone, Potassium)

    Not yet recruiting
    • Hypertension
    • Left Ventricular Hypertrophy
    • (no location specified)
    Oct 26, 2022

    Cardiac Surgery, Atrial Fibrillation, Aldosterone Blockade Trial in Caen (Spironolactone 25mg, Placebo oral capsule)

    Unknown status
    • Cardiac Surgery
    • +2 more
    • Spironolactone 25mg
    • Placebo oral capsule
    • Caen, Normandy, France
    • +1 more
    Mar 2, 2019

    Hypertension, Mineralocorticoid Excess Trial in Boston (Eplerenone, Amlodipine)

    Recruiting
    • Hypertension
    • Mineralocorticoid Excess
    • Boston, Massachusetts
      Brigham and Women's
    Jul 20, 2022

    Hypertension, Genetics Hypertension Trial in Boston (Eplerenone vs Amlodipine)

    Recruiting
    • Hypertension
    • Genetics Hypertension
    • Eplerenone vs Amlodipine
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Nov 11, 2021

    Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)

    Recruiting
    • Hypertension
    • +17 more
      • Winston-Salem, North Carolina
        Wake Forest Health Sciences
      Jan 3, 2023

      Hypertension, Hypertension, Essential Trial in Nashville (Angiotensin (1-7), Trimethaphan, Phenylephrine)

      Active, not recruiting
      • Hypertension
      • Hypertension, Essential
      • Angiotensin (1-7)
      • +2 more
      • Nashville, Tennessee
        Vanderbilt University
      Jan 2, 2023

      Angiotensin/Renin/Aldosterone Hypertension, Hypertension, Diabetes, Type 2 Trial in Seongnam (Olmesartan)

      Recruiting
      • Angiotensin/Renin/Aldosterone Hypertension
      • +2 more
      • Seongnam, Gyeonggi, Korea, Republic of
        Seoul National University Bundang Hospital
      Aug 16, 2022

      Hypertension Resistant to Conventional Therapy Trial in São José do Rio Preto (Spironolactone, Furosemide,, Amiloride)

      Completed
      • Hypertension Resistant to Conventional Therapy
      • São José do Rio Preto, São Paulo, Brazil
        Juan Carlos Yugar-Toledo
      Apr 3, 2019

      Myocardial Fibrosis, Hypertrophic Cardiomyopathy Trial in Boston (Spironolactone, Placebo)

      Completed
      Has Results
      • Myocardial Fibrosis
      • Hypertrophic Cardiomyopathy
      • Boston, Massachusetts
        Tufts Medical Center
      Mar 31, 2021

      Primary Aldosteronism in Hypertension With 24-hour URinary

      Recruiting
      • Hypertension
      • +2 more
        • Cambridge, United Kingdom
          Vascular Research Clinic, Adenbrooke's Centre of Clinical Invest
        Sep 15, 2023

        Atrial Fibrillation Trial in Chicago (Parasym)

        Completed
        Has Results
        • Atrial Fibrillation
        • Parasym
        • Chicago, Illinois
          The University of Chicago
        Jul 11, 2022

        PreDiabetes, Impaired Glucose Tolerance, Obesity Trial in Columbus (Sacubitril-Valsartan Tab 97-103 MG, Valsartan 160mg, Placebo

        Recruiting
        • PreDiabetes
        • +3 more
        • Sacubitril-Valsartan Tab 97-103 MG
        • +2 more
        • Columbus, Ohio
          The Ohio State University Wexner Medical Center
        Jul 21, 2022

        Cardiorenal Effecs of Losartan in Kidney Transplant Recipients

        Recruiting
        • Renal Transplant Failure
        • Cardiovascular Complication
        • Gdansk, Poland
          Medical University
        Feb 3, 2022

        Mastectomy, Breast Cancer Trial in Ismailia (PECS block, SAP block)

        Completed
        • Mastectomy
        • Breast Cancer
        • PECS block, SAP block
        • Ismailia, Egypt
          Suez Canal University
        Aug 4, 2022

        Aldosterone-producing Adenoma and Unilateral Hyperplasia

        Not yet recruiting
        • Primary Aldosteronism Due to Aldosterone Producing Adenoma
        • Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
        • histopathology
        • Chongqing, China
          The Third Affiliated Hospital of the Third Military Medical Univ
        Jun 28, 2023

        Hypertension Trial in Burke (lorundrostat, Placebo)

        Recruiting
        • Hypertension
        • Burke, Virginia
          Burke Internal Medicine
        Aug 2, 2023

        Hypertension Trial (Placebo, lorundrostat Dose 1, lorundrostat Dose 2)

        Not yet recruiting
        • Hypertension
        • Placebo
        • +2 more
        • (no location specified)
        Nov 22, 2023

        Hyperaldosteronism; Primary Trial in Caen (Aldosterone in HPLC-MS/MS)

        Recruiting
        • Hyperaldosteronism; Primary
        • Aldosterone in HPLC-MS/MS
        • Caen, France
          CAEN University Hospital
        Nov 28, 2022